Incentives for Research, Development, and Innovation in Pharmaceuticals

✍ Scribed by Walter García-Fontes (DIR.) (auth.)

• Publisher: Springer Healthcare Communications
• Year: 2011
• Tongue: English
• Leaves: 104
• Series: Economía de la Salud y Gestión Sanitaria
• Edition: 1
• Category: Library

✦ Synopsis

Incentives for innovation are particularly relevant in the pharmaceutical

industry where not all social needs provide equally profitable

opportunities and where most OECD countries try to implement diffe -

rent measures that promote research in these less profitable areas. The

lack of incentives for innovation is especially dramatic when we take

into account diseases affecting mostly low-income countries, and also

diseases affecting small groups of patients.

How can incentives be provided to deal with these less profitable acti -

vities when no clear markets exist for the innovations being introduced?

Some of the contributions of this book go into discussing alternative

mechanisms to substitute for these inexistent markets, and

situations where traditional instruments such as public procurement or

direct subsidies have proven totally insufficient. Also, this book discusses

the clear mismatch between the size of the markets being targeted and

the incentives being provided.

✦ Table of Contents

Front Matter....Pages I-IX
Introduction....Pages 1-4
Incentives to innovate: A survey....Pages 5-14
Incentives for innovation: Neglected diseases....Pages 15-38
When patents are not enough: Supplementary incentives for pharmaceutical innovation....Pages 39-47
The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982–2003....Pages 49-68
The use of pay-for-performance for drugs: Can it improve incentives for innovation?....Pages 69-80
Drug Price Regulation: Recent Trends and Downstream Neglected Issues....Pages 81-96

✦ Subjects

Health Promotion and Disease Prevention; Health Economics; Health Informatics; Medicine/Public Health, general